It was preliminarily proven that TRPV1 might regulate inflammatory factors through the PI3K/AKT pathway, thereby affecting the occurrence and progression of bone destruction and providing new approaches to the diagnosis and treatment of patients with periodontitis. Here, TRPV1 is linked to periodontitis.